Indivac Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 14.76%
(FY 2023)
- Profit 96.41%
(FY 2023)
- Ebitda 85.32%
(FY 2023)
- Net Worth -0.86%
(FY 2023)
- Total Assets 6.61%
(FY 2023)
About Indivac Healthcare
The Corporate was formerly known as Manjari Devcon Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Agrawal, Kailash Agarwal, and Shambhu Choubey serve as directors at the Company.
- CIN/LLPIN
U85100WB2012PTC186512
- Company No.
186512
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Indivac Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Agrawal  | Director | 16-Jul-2015 | Current |
| Kailash Agarwal | Director | 27-Sep-2012 | Current |
| Shambhu Choubey | Director | 20-Aug-2017 | Current |
Financial Performance of Indivac Healthcare.
Indivac Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.76% increase. The company also saw a substantial improvement in profitability, with a 96.41% increase in profit. The company's net worth dipped by a decrease of 0.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indivac Healthcare?
In 2023, Indivac Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Pace Biotech Private LimitedActive 33 years 1 month
Amit Agrawal and Kailash Agarwal are mutual person
- Gochem Speciality Chemicals Private LimitedActive 3 years 5 months
Amit Agrawal and Kailash Agarwal are mutual person
- Ravetaara Diabetics Private LimitedActive 20 years 10 months
Amit Agrawal and Shambhu Choubey are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indivac Healthcare?
Unlock and access historical data on people associated with Indivac Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indivac Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indivac Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
